학술논문
Safety and efficacy of MIKE-1 in patients with advanced pancreatic cancer: a study protocol for an open-label phase I/II investigator-initiated clinical trial based on a drug repositioning approach that reprograms the tumour stroma
Document Type
Article
Author
Source
In: BMC Cancer . (BMC Cancer, December 2022, 22(1))
Subject
Language
English
ISSN
14712407